Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HeZhong JianPi Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Shanghai Municipal Hospital of Traditional Chinese Medicine for the treatment of gastroesophageal reflux disease (GERD). The formula is specifically investigated for its potential to assist in the withdrawal of proton pump inhibitors (PPIs) in patients with PPI-dependent GERD. Its therapeutic rationale is based on the TCM principles of "HeZhong" (harmonizing the middle burner/stomach) and "JianPi" (strengthening the spleen) to address gastrointestinal dysfunction. Clinical trials conducted in Shanghai have evaluated the decoction's efficacy both as a standalone therapy and in combination with Western medications like rabeprazole and omeprazole to facilitate drug withdrawal and prevent symptom recurrence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HeZhong JianPi Decoction.